May 25, 2018 5:21 AM ET


Company Overview of Cypress Bioscience, Inc.

Company Overview

Cypress Bioscience, Inc. was acquired by Ramius, LLC and Royalty Pharma. Cypress Bioscience, Inc. engages in the development of drugs for patients suffering from various disorders of the central nervous system. The company offers Savella, a milnacipran HCl for the treatment of fibromyalgia; and Prosorba, a medical device for rheumatoid arthritis. Its development-stage products comprise CYP-1020 for the treatment of cognitive impairment in schizophrenia; Staccato nicotine, an electronic multidose delivery technology for people to stop smoking; and Carbetocin, an intranasal formulation for the treatment of autism. The company was formerly known as IMRE Corporation and changed its name to Cypre...

4350 Executive Drive

Suite 325

San Diego, CA 92121

United States

Founded in 1981

23 Employees





Key Executives for Cypress Bioscience, Inc.

Cypress Bioscience, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cypress Bioscience, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at